| Sign In to gain access to subscriptions and/or personal tools. |
Treatment of NIDDM in YouthDepartment of Pediatrics, Nihon University Hospital, Tokyo, Japan
Department of Pediatrics, Nihon University Hospital, Tokyo, Japan
Department of Pediatrics, Nihon University Hospital, Tokyo, Japan This study presents the characteristics of 20 children (17 female) with NIDDM who required oral hypoglycemic agent (OHA) therapy. A family history of NIDDM was present in 55%. None had islet cell antibodies (ICA) or glutamic acid decarboxylase (GAD) antibodies. Tolbutamide was the drug of choice; glibenclamide was introduced if glycemic control was not obtained after 2 to 3 months of tolbutamide therapy. Seven of the patients eventually required insulin therapy. Clin Pediatr. 1998;37:117-122
Clinical Pediatrics, Vol. 37, No. 2,
117-121 (1998) |
|
||

